Harvard scientists have found evidence to support long-standing anecdotes that stress turns hair gray.

Harvard stem-cell research receives support from Sarepta Therapeutics for work on Duchenne muscular dystrophy.

Harvard researchers have unveiled the first stem cell models of human spine development, setting the stage for better understanding of musculoskeletal and metabolic disorders, including congenital scoliosis, muscular dystrophy, and Type 2 diabetes.

A new technique called SWIFT (sacrificial writing into functional tissue) ultimately may be used therapeutically to repair and replace human organs with lab-grown versions containing patients’ own cells.

Harvard researchers have devised a time-saving method that makes it possible to speed up the process of profiling gene regulation in tens of thousands of individual human cells in a single day, a development that promises to boost genomics research.

The combination of the antibody CD117 and the drug saporin selectively targets blood stem cells, making transplantation safer by limiting collateral damage caused by the current standard of treatment, chemotherapy, and radiation.

Scientists at the Harvard Stem Cell Institute are seeking ways to protect newly transplanted cells from autoimmune attack.